ARCHIVES

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Senate Committee Directs NCI To Conduct Research To Eliminate Barriers To Enrollment On Clinical Trials.

July 6, 2007

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992

NCI-Approved Clinical Trials

July 30, 2010

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988